Icterus (Jaundice) - Causes, Treatment & When to See a Doctor

What is Icterus (Jaundice)?

Icterus, more commonly known as jaundice, is a visible yellowing of the skin, sclerae (the whites of the eyes), and mucous membranes caused by an excess of bilirubin in the bloodstream. Bilirubin is a yellow‑orange pigment produced when red blood cells break down. Under normal circumstances the liver processes bilirubin, turning it water‑soluble so it can be eliminated in bile and urine. When this pathway is disrupted—by over‑production, impaired uptake, or blocked excretion—bilirubin accumulates, leading to the characteristic discoloration.

Jaundice is not a disease itself; it is a clinical sign that signals an underlying problem in the liver, gallbladder, pancreas, or red‑blood‑cell turnover. Recognizing jaundice early can help identify serious conditions before they progress.

Sources: Mayo Clinic, CDC, NIH

Common Causes

Jaundice can arise from many different mechanisms. Below are the most frequently encountered causes, grouped by the primary pathway that is disrupted.

• Hemolytic anemia – accelerated breakdown of red blood cells (e.g., sickle‑cell disease, hereditary spherocytosis, autoimmune hemolysis).
• Viral hepatitis – inflammation of the liver caused by hepatitis A, B, C, D, or E viruses.
• Alcoholic liver disease – chronic alcohol consumption leading to fatty liver, hepatitis, and cirrhosis.
• Non‑alcoholic fatty liver disease (NAFLD) – accumulation of fat in liver cells associated with obesity and metabolic syndrome.
• Biliary obstruction – gallstones, strictures, or tumors blocking the bile ducts (e.g., cholangiocarcinoma, pancreatic head cancer).
• Gilbert’s syndrome – a benign genetic condition that reduces the liver’s ability to conjugate bilirubin.
• Drug‑induced liver injury – certain medications (e.g., acetaminophen overdose, isoniazid, certain antibiotics) can damage hepatocytes.
• Sepsis or severe infection – systemic inflammation can impair liver function and cause cholestasis.
• Neonatal physiologic jaundice – common in newborns due to immature liver enzymes; usually resolves within two weeks.
• Genetic disorders of bilirubin metabolism – such as Crigler‑Najjar syndrome or Dubin‑Johnson syndrome.

Each cause may present with a slightly different pattern of bilirubin elevation (unconjugated vs. conjugated) and associated clinical features.

Associated Symptoms

Jaundice often appears alongside other signs that reflect the underlying disease. Common accompanying symptoms include:

• Dark urine (due to conjugated bilirubin excreted by the kidneys)
• Pale or clay‑colored stools (suggesting bile flow obstruction)
• Itching (pruritus) – especially in cholestatic jaundice
• Abdominal pain or fullness, particularly in the right upper quadrant
• Fatigue and generalized weakness
• Unexplained weight loss
• Fever or chills (possible infection)
• Swelling of the abdomen (ascites) or legs (edema) in advanced liver disease
• Confusion or altered mental status (hepatic encephalopathy)

When to See a Doctor

Because jaundice can signal serious illness, prompt medical evaluation is recommended when any of the following occur:

• Yellowing of the eyes or skin that persists longer than 24 hours.
• Accompanying dark urine, pale stools, or intense itching.
• Severe abdominal pain, especially in the right upper quadrant.
• Fever, chills, or signs of infection.
• Sudden weight loss, loss of appetite, or persistent nausea/vomiting.
• Confusion, drowsiness, or difficulty concentrating.
• History of liver disease, recent travel to areas with hepatitis, or recent use of potentially hepatotoxic medications.
• In infants: yellowing that spreads beyond the face, appears after the first 24 hours of life, or is accompanied by poor feeding or lethargy.

Early evaluation can prevent complications and guide appropriate treatment.

Diagnosis

Diagnosing the cause of jaundice involves a stepwise approach that combines history, physical examination, laboratory testing, and imaging.

Laboratory Tests

• Serum bilirubin levels – total, direct (conjugated), and indirect (unconjugated) bilirubin help differentiate the pathway of dysfunction.
• Liver function panel – ALT, AST, alkaline phosphatase (ALP), gamma‑glutamyl transferase (GGT), and albumin assess hepatocellular injury vs. cholestasis.
• Complete blood count (CBC) – looks for anemia, leukocytosis, or platelet abnormalities.
• Hemolysis work‑up – haptoglobin, lactate dehydrogenase (LDH), reticulocyte count, and peripheral smear if hemolytic anemia is suspected.
• Viral hepatitis serologies – hepatitis A IgM, hepatitis B surface antigen & core antibody, hepatitis C antibody, etc.
• Autoimmune markers – ANA, anti‑smooth muscle, anti‑LKM1 for autoimmune hepatitis.
• Coagulation profile – PT/INR to gauge liver synthetic function.

Imaging Studies

• Abdominal ultrasound – first‑line to assess gallstones, bile duct dilation, liver texture, and vascular flow.
• CT or MRI of the abdomen – provides detailed anatomy for tumors, strictures, or complex biliary disease.
• Magnetic resonance cholangiopancreatography (MRCP) – non‑invasive visualization of the biliary tree.
• Endoscopic retrograde cholangiopancreatography (ERCP) – diagnostic and therapeutic (e.g., stone removal) but reserved for selected cases.

Special Tests

• Liver biopsy – indicated when imaging and labs cannot pinpoint the cause (e.g., distinguishing autoimmune hepatitis from drug‑induced injury).
• Genetic testing – for suspected hereditary bilirubin disorders such as Gilbert’s or Crigler‑Najjar syndrome.

Treatment Options

Treatment is directed at the underlying cause and at relieving symptoms. Below are the main therapeutic categories.

Medical Management

• Antiviral therapy – for chronic hepatitis B (e.g., tenofovir, entecavir) or C (direct‑acting antivirals).
• Corticosteroids or immunosuppressants – used in autoimmune hepatitis or severe drug‑induced injury.
• Ursodeoxycholic acid (UDCA) – improves bile flow in cholestatic diseases such as primary biliary cholangitis.
• Phototherapy – the mainstay for neonatal jaundice; blue‑light converts bilirubin into water‑soluble isomers.
• Exchange transfusion – reserved for severe neonatal hyperbilirubinemia at risk for kernicterus.
• Antibiotics – indicated when bacterial cholangitis or sepsis is present.
• Chemo‑ or targeted therapy – for malignant causes (e.g., pancreatic cancer) after oncologic evaluation.

Procedural Interventions

• Endoscopic stone extraction (ERCP) – removes obstructing gallstones or biliary sludge.
• Percutaneous transhepatic biliary drainage – provides temporary relief when ERCP is not feasible.
• Surgical cholecystectomy – definitive treatment for gallstone disease causing obstruction.
• Liver transplantation – for end‑stage liver disease or acute liver failure when other measures fail.

Home & Supportive Care

• Maintain adequate hydration – helps the kidneys excrete bilirubin.
• Follow a low‑fat, high‑fiber diet if gallbladder disease is suspected.
• Avoid alcohol and hepatotoxic substances.
• Use over‑the‑counter antihistamines or cholestyramine for itching, after discussing with a clinician.
• Monitor weight and urine/stool color; keep a symptom diary for follow‑up visits.

Prevention Tips

While some causes (e.g., genetic syndromes) cannot be prevented, many risk factors are modifiable.

• Vaccinate against hepatitis A and B.
• Practice safe sex and avoid sharing needles to reduce hepatitis C transmission.
• Limit alcohol intake – no more than one drink per day for women and two for men.
• Maintain a healthy weight – reduces risk of NAFLD.
• Use medications responsibly – follow dosing instructions and discuss liver‑related side effects with your provider.
• Eat a balanced diet rich in fruits, vegetables, whole grains, and lean protein.
• Stay up‑to‑date on routine health screenings (e.g., liver function tests for patients with chronic disease).
• Promptly treat infections – especially urinary or biliary infections that can ascend to the liver.

Emergency Warning Signs

If you experience any of the following, seek emergency medical care (call 911 or go to the nearest emergency department) immediately:

• Sudden, severe abdominal pain with a rigid or board‑like abdomen.
• Rapidly worsening confusion, drowsiness, or inability to stay awake (possible hepatic encephalopathy).
• High fever (> 101 °F / 38.3 °C) with chills and jaundice – may indicate cholangitis.
• Vomiting blood (hematemesis) or passing black, tarry stools (melena) – signs of gastrointestinal bleeding.
• Rapidly increasing yellowing of the skin/eyes accompanied by shortness of breath.
• New onset of severe itching that interferes with sleep or daily activities.

---

References

1. Mayo Clinic. “Jaundice.” https://www.mayoclinic.org. Accessed February 2026.
2. Centers for Disease Control and Prevention. “Hepatitis A, B, C – Prevention & Treatment.” https://www.cdc.gov. Accessed February 2026.
3. National Institutes of Health. “Liver Disease: Diagnosis and Management.” https://www.niddk.nih.gov. Accessed February 2026.
4. World Health Organization. “Viral Hepatitis.” https://www.who.int. Accessed February 2026.
5. Cleveland Clinic. “Biliary Obstruction.” https://my.clevelandclinic.org. Accessed February 2026.
6. American College of Gastroenterology. “Guidelines for the Management of Acute Pancreatitis.” Gastroenterology, 2023.